-
1
-
-
84870710995
-
General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine
-
3485619, 23116135, EPMA
-
Golubnitschaja O, Costigliola V, . EPMA General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J 2012, 3:14. 10.1186/1878-5085-3-14, 3485619, 23116135, EPMA.
-
(2012)
EPMA J
, vol.3
, pp. 14
-
-
Golubnitschaja, O.1
Costigliola, V.2
-
2
-
-
85042808027
-
Information and communication technology in personalised medicine: a clinical use-case for hepatocellular cancer
-
Berliner L, Lemke HU, van Sonnenberg E, Ashamalla H, Mattes MD, Dosik D, Hazin H, Shah S, Mohanty S, Verma S, Esposito G, Bargellini I. Information and communication technology in personalised medicine: a clinical use-case for hepatocellular cancer. EPMA J 2014, 5(Suppl 1):A59.
-
(2014)
EPMA J
, vol.5
-
-
Berliner, L.1
Lemke, H.U.2
van Sonnenberg, E.3
Ashamalla, H.4
Mattes, M.D.5
Dosik, D.6
Hazin, H.7
Shah, S.8
Mohanty, S.9
Verma, S.10
Esposito, G.11
Bargellini, I.12
-
3
-
-
84927703421
-
-
Springer, In press
-
Berliner L, Lemke HU, van Sonnenberg E, Ashamalla H, Mattes MD, Dosik D, Hazin H, Shah S, Mohanty S, Verma S, Esposito G, Bargellini I. An Information Technology Framework for PPPM: a Use-Case with Hepatocellular Carcinoma, Advances in PPPM book series 2014, Springer, In press.
-
(2014)
An Information Technology Framework for PPPM: a Use-Case with Hepatocellular Carcinoma, Advances in PPPM book series
-
-
Berliner, L.1
Lemke, H.U.2
van Sonnenberg, E.3
Ashamalla, H.4
Mattes, M.D.5
Dosik, D.6
Hazin, H.7
Shah, S.8
Mohanty, S.9
Verma, S.10
Esposito, G.11
Bargellini, I.12
-
4
-
-
78650445203
-
-
Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services, Accessed 7/27/2014
-
Armijo D, McDonnell C, Werner K. Electronic health record usability: evaluation and use case framework 2009, Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services, Accessed 7/27/2014. (http://www.himss.org/files/HIMSSorg/content/files/Code%20119%20-%20EHR%20Usability_Evaluation%20and%20Use%20Case%20Framework_AHRQ.pdf).
-
(2009)
Electronic health record usability: evaluation and use case framework
-
-
Armijo, D.1
McDonnell, C.2
Werner, K.3
-
5
-
-
84927703420
-
Module 1. UML fundamentals
-
Berkley, CA: McGraw-Hill/Osborne
-
Roff JT. Module 1. UML fundamentals. UML: a Beginner's Guide 2003, Berkley, CA: McGraw-Hill/Osborne.
-
(2003)
UML: a Beginner's Guide
-
-
Roff, J.T.1
-
6
-
-
84894277950
-
Personalised medicine and model-guided therapy
-
Dresden: Health Academy, Niederlag W, Lemke HU O, Rienhoff O
-
Lemke HU, Berliner L. Personalised medicine and model-guided therapy. Personalisierte Medizin und Informationstechnologie, 15 2010, 39-48. Dresden: Health Academy, Niederlag W, Lemke HU O, Rienhoff O.
-
(2010)
Personalisierte Medizin und Informationstechnologie
, vol.15
, pp. 39-48
-
-
Lemke, H.U.1
Berliner, L.2
-
7
-
-
84878383914
-
Personalised medicine and patient-specific modelling
-
Dresden: Health Academy, Niederlag W, Lemke HU, Golubnitschaja O, Rienhoff O
-
Lemke HU, Berliner L. Personalised medicine and patient-specific modelling. Personalisierte Medizin, 14 2010, 155-164. Dresden: Health Academy, Niederlag W, Lemke HU, Golubnitschaja O, Rienhoff O.
-
(2010)
Personalisierte Medizin
, vol.14
, pp. 155-164
-
-
Lemke, H.U.1
Berliner, L.2
-
8
-
-
37249020564
-
MEBN: a language for first-order Bayesian knowledge bases
-
Laskey KB. MEBN: a language for first-order Bayesian knowledge bases. Artif Intell 2008, 172:140-178.
-
(2008)
Artif Intell
, vol.172
, pp. 140-178
-
-
Laskey, K.B.1
-
10
-
-
70449598134
-
-
Adobe Systems Inc, Accessed online 6 January 2009
-
Nickul D, Reitman L, Ward J, Wilber J. Service Oriented Architecture (SOA) and Specialized Messaging Patterns Technical; White Paper 2007, Adobe Systems Inc, http://www.adobe.com/enterprise/pdfs/Services_Oriented_Architecture_from_Adobe.pdf Accessed online 6 January 2009.
-
(2007)
Service Oriented Architecture (SOA) and Specialized Messaging Patterns Technical; White Paper
-
-
Nickul, D.1
Reitman, L.2
Ward, J.3
Wilber, J.4
-
11
-
-
79952232216
-
Global cancer statistics
-
21296855
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
12
-
-
79959294956
-
Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy
-
21689611
-
Roskams T. Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy. Clin Liver Dis 2011, 15:245-259. 10.1016/j.cld.2011.03.004, 21689611.
-
(2011)
Clin Liver Dis
, vol.15
, pp. 245-259
-
-
Roskams, T.1
-
13
-
-
77951622187
-
Viral hepatocarcinogenesis
-
3148694, 20228847
-
Tsai W-L, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010, 29:2309-2324. 10.1038/onc.2010.36, 3148694, 20228847.
-
(2010)
Oncogene
, vol.29
, pp. 2309-2324
-
-
Tsai, W.-L.1
Chung, R.T.2
-
14
-
-
33748114343
-
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
-
16879891
-
Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538. 10.1016/j.jhep.2006.05.013, 16879891.
-
(2006)
J Hepatol
, vol.45
, pp. 529-538
-
-
Perz, J.F.1
Armstrong, G.L.2
Farrington, L.A.3
Hutin, Y.J.4
Bell, B.P.5
-
15
-
-
34250020201
-
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis
-
17570226
-
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576. 10.1053/j.gastro.2007.04.061, 17570226.
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Rudolph, K.L.2
-
16
-
-
0032579547
-
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
-
9455792
-
Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998, 75:347-354. 10.1002/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2, 9455792.
-
(1998)
Int J Cancer
, vol.75
, pp. 347-354
-
-
Donato, F.1
Boffetta, P.2
Puoti, M.3
-
17
-
-
0037083159
-
Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women
-
Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, Decarli A, Trevisi P, Ribero ML, Martelli C, Porru S, Nardi G. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002, 155:323-331. 10.1093/aje/155.4.323, 11836196.
-
(2002)
Am J Epidemiol
, vol.155
, pp. 323-331
-
-
Donato, F.1
Tagger, A.2
Gelatti, U.3
Parrinello, G.4
Boffetta, P.5
Albertini, A.6
Decarli, A.7
Trevisi, P.8
Ribero, M.L.9
Martelli, C.10
Porru, S.11
Nardi, G.12
-
18
-
-
66149177153
-
National Institutes of Health consensus development conference statement: management of hepatitis B
-
Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT. National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology 2009, 49(5 Suppl):S4-S12.
-
(2009)
Hepatology
, vol.49
, Issue.5
, pp. S4-S12
-
-
Sorrell, M.F.1
Belongia, E.A.2
Costa, J.3
Gareen, I.F.4
Grem, J.L.5
Inadomi, J.M.6
Kern, E.R.7
McHugh, J.A.8
Petersen, G.M.9
Rein, M.F.10
Strader, D.B.11
Trotter, H.T.12
-
19
-
-
58149460674
-
Treatment failure in hepatitis C: mechanisms of non-response
-
2743341, 19070928
-
Tai AW, Chung RT. Treatment failure in hepatitis C: mechanisms of non-response. J Hepatol 2009, 50:412-420. 10.1016/j.jhep.2008.11.010, 2743341, 19070928.
-
(2009)
J Hepatol
, vol.50
, pp. 412-420
-
-
Tai, A.W.1
Chung, R.T.2
-
20
-
-
58849143425
-
The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology
-
Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009, 44(Suppl XIX):96-101.
-
(2009)
J Gastroenterol
, vol.44
, pp. 96-101
-
-
Caldwell, S.1
Park, S.H.2
-
21
-
-
0037325438
-
Natural history and prognosis of hepatitis B
-
Fattovich G. Natural history and prognosis of hepatitis B. Sem Liver Diseas 2003, 23:47-58.
-
(2003)
Sem Liver Diseas
, vol.23
, pp. 47-58
-
-
Fattovich, G.1
-
22
-
-
0034027972
-
Improved survival with screening for hepatocellular carcinoma
-
10827233
-
Wong LL, Limm WM, Severino R, Wong LM. Improved survival with screening for hepatocellular carcinoma. Liver Transpl 2000, 6:320-325. 10.1053/lv.2000.4875, 10827233.
-
(2000)
Liver Transpl
, vol.6
, pp. 320-325
-
-
Wong, L.L.1
Limm, W.M.2
Severino, R.3
Wong, L.M.4
-
23
-
-
3843125293
-
Randomized controlled trial of screening for hepatocellular carcinoma
-
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130:417-422.
-
(2004)
J Cancer Res Clin Oncol
, vol.130
, pp. 417-422
-
-
Zhang, B.H.1
Yang, B.H.2
Tang, Z.Y.3
-
24
-
-
77958070977
-
Current treatment strategies for hepatocellular carcinoma
-
Aronsohn A, Mohanty SR. Current treatment strategies for hepatocellular carcinoma. Curr Cancer Ther Rev 2010, 6:199-206.
-
(2010)
Curr Cancer Ther Rev
, vol.6
, pp. 199-206
-
-
Aronsohn, A.1
Mohanty, S.R.2
-
25
-
-
0035128185
-
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
-
1728189, 11156649
-
Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001, 48:251-259. 10.1136/gut.48.2.251, 1728189, 11156649.
-
(2001)
Gut
, vol.48
, pp. 251-259
-
-
Bolondi, L.1
Sofia, S.2
Siringo, S.3
Gaiani, S.4
Casali, A.5
Zironi, G.6
Piscaglia, F.7
Gramantieri, L.8
Zanetti, M.9
Sherman, M.10
-
26
-
-
0025248538
-
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review
-
Wu JT. Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann Clin Lab Sci 1990, 20:98-105.
-
(1990)
Ann Clin Lab Sci
, vol.20
, pp. 98-105
-
-
Wu, J.T.1
-
27
-
-
0035059885
-
Alphafetoprotein: an obituary
-
11394662
-
Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001, 34:603-605. 10.1016/S0168-8278(01)00025-3, 11394662.
-
(2001)
J Hepatol
, vol.34
, pp. 603-605
-
-
Sherman, M.1
-
28
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: the BCLC staging classification
-
10518312
-
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999, 19:329-338. 10.1055/s-2007-1007122, 10518312.
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Bru, C.2
Bruix, J.3
-
29
-
-
84858658381
-
European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
-
European Association for the Study of the Liver
-
European Association for the Study of the Liver European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012, 56:908-943. European Association for the Study of the Liver.
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
-
30
-
-
79952231921
-
AASLD PRACTICE GUIDELINE. Management of hepatocellular carcinoma: an update
-
3084991, 21374666
-
Sherman M, Bruix J. AASLD PRACTICE GUIDELINE. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022. 10.1002/hep.24199, 3084991, 21374666.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Sherman, M.1
Bruix, J.2
-
31
-
-
79951791027
-
AASLD Practice Guideline. Management of hepatocellular carcinoma
-
Accessed 20 November 2011
-
Bruix J, Sherman M. AASLD Practice Guideline. Management of hepatocellular carcinoma. Hepatology 2010, http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf. Accessed 20 November 2011.
-
(2010)
Hepatology
-
-
Bruix, J.1
Sherman, M.2
-
32
-
-
42949174616
-
Diagnosis and treatment of hepatocellular carcinoma
-
18471552
-
El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008, 134:1752-1763. 10.1053/j.gastro.2008.02.090, 18471552.
-
(2008)
Gastroenterology
, vol.134
, pp. 1752-1763
-
-
El-Serag, H.B.1
Marrero, J.A.2
Rudolph, L.3
Reddy, K.R.4
-
33
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
18650514, SHARP Investigators Study Group
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, . SHARP Investigators Study Group Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390. 10.1056/NEJMoa0708857, 18650514, SHARP Investigators Study Group.
-
(2008)
N Engl J Med
, vol.359
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
De Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.F.15
Galle, P.R.16
Seitz, J.F.17
Borbath, I.18
Häussinger, D.19
Giannaris, T.20
Shan, M.21
Moscovici, M.22
Voliotis, D.23
Bruix, J.24
more..
-
34
-
-
0035986529
-
Dysplastic nodules and hepatocarcinogenesis
-
12122867
-
Theise ND, Park YN, Kojiro M. Dysplastic nodules and hepatocarcinogenesis. Clin Liver Dis 2002, 6:497-512. 10.1016/S1089-3261(02)00006-5, 12122867.
-
(2002)
Clin Liver Dis
, vol.6
, pp. 497-512
-
-
Theise, N.D.1
Park, Y.N.2
Kojiro, M.3
-
35
-
-
61949171989
-
Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia
-
International Consensus Group for Hepatocellular Neoplasia
-
International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology 2009, 49:658-664. International Consensus Group for Hepatocellular Neoplasia.
-
(2009)
Hepatology
, vol.49
, pp. 658-664
-
-
-
36
-
-
84879502464
-
Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers
-
23053453
-
Bartolozzi C, Battaglia V, Bargellini I, Bozzi E, Campani D, Pollina LE, Filipponi F. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 2013, 38:290-296. 10.1007/s00261-012-9952-9, 23053453.
-
(2013)
Abdom Imaging
, vol.38
, pp. 290-296
-
-
Bartolozzi, C.1
Battaglia, V.2
Bargellini, I.3
Bozzi, E.4
Campani, D.5
Pollina, L.E.6
Filipponi, F.7
-
37
-
-
38649114052
-
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
-
Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008, 47:97-104.
-
(2008)
Hepatology
, vol.47
, pp. 97-104
-
-
Forner, A.1
Vilana, R.2
Ayuso, C.3
Bianchi, L.4
Solé, M.5
Ayuso, J.R.6
Boix, L.7
Sala, M.8
Varela, M.9
Llovet, J.M.10
Brú, C.11
Bruix, J.12
-
38
-
-
77951707718
-
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
-
19951909
-
Sangiovanni A, Manini MA, Iavarone M, Romeo R, Forzenigo LV, Fraquelli M, Massironi S, Della Corte C, Ronchi G, Rumi MG, Biondetti P, Colombo M. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 2010, 59:638-644. 10.1136/gut.2009.187286, 19951909.
-
(2010)
Gut
, vol.59
, pp. 638-644
-
-
Sangiovanni, A.1
Manini, M.A.2
Iavarone, M.3
Romeo, R.4
Forzenigo, L.V.5
Fraquelli, M.6
Massironi, S.7
Della Corte, C.8
Ronchi, G.9
Rumi, M.G.10
Biondetti, P.11
Colombo, M.12
-
39
-
-
21344450714
-
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma
-
Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005, 42:27-34.
-
(2005)
Hepatology
, vol.42
, pp. 27-34
-
-
Bolondi, L.1
Gaiani, S.2
Celli, N.3
Golfieri, R.4
Grigioni, W.F.5
Leoni, S.6
Venturi, A.M.7
Piscaglia, F.8
-
40
-
-
84984586846
-
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
-
2900561, 20827404
-
Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010, 4:439-474. 10.1007/s12072-010-9165-7, 2900561, 20827404.
-
(2010)
Hepatol Int
, vol.4
, pp. 439-474
-
-
Omata, M.1
Lesmana, L.A.2
Tateishi, R.3
Chen, P.J.4
Lin, S.M.5
Yoshida, H.6
Kudo, M.7
Lee, J.M.8
Choi, B.I.9
Poon, R.T.10
Shiina, S.11
Cheng, A.L.12
Jia, J.D.13
Obi, S.14
Han, K.H.15
Jafri, W.16
Chow, P.17
Lim, S.G.18
Chawla, Y.K.19
Budihusodo, U.20
Gani, R.A.21
Lesmana, C.R.22
Putranto, T.A.23
Liaw, Y.F.24
Sarin, S.K.25
more..
-
41
-
-
84876698401
-
Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤2.0 cm) in patients with hepatitis-induced liver cirrhosis
-
23148300
-
Park MJ, Kim YK, Lee MH, Lee JH. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (≤2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol 2013, 54:127-136. 10.1258/ar.2012.120262, 23148300.
-
(2013)
Acta Radiol
, vol.54
, pp. 127-136
-
-
Park, M.J.1
Kim, Y.K.2
Lee, M.H.3
Lee, J.H.4
-
42
-
-
84866606349
-
Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC
-
22891358
-
Kim YK, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Radiology 2012, 265:104-114. 10.1148/radiol.12112649, 22891358.
-
(2012)
Radiology
, vol.265
, pp. 104-114
-
-
Kim, Y.K.1
Lee, W.J.2
Park, M.J.3
Kim, S.H.4
Rhim, H.5
Choi, D.6
-
43
-
-
84865423409
-
Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns
-
22843769
-
Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Radiology 2012, 264:761-770. 10.1148/radiol.12112517, 22843769.
-
(2012)
Radiology
, vol.264
, pp. 761-770
-
-
Park, M.J.1
Kim, Y.K.2
Lee, M.W.3
Lee, W.J.4
Kim, Y.S.5
Kim, S.H.6
Choi, D.7
Rhim, H.8
-
44
-
-
0034541463
-
Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging
-
11012437
-
Ichikawa T, Cederle MP, Grazioli L, Marsh W. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology 2000, 217:145-151. 10.1148/radiology.217.1.r00se46145, 11012437.
-
(2000)
Radiology
, vol.217
, pp. 145-151
-
-
Ichikawa, T.1
Cederle, M.P.2
Grazioli, L.3
Marsh, W.4
-
45
-
-
39149092066
-
Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions
-
17994317
-
Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008, 18:486-492. 10.1007/s00330-007-0798-4, 17994317.
-
(2008)
Eur Radiol
, vol.18
, pp. 486-492
-
-
Gourtsoyianni, S.1
Papanikolaou, N.2
Yarmenitis, S.3
Maris, T.4
Karantanas, A.5
Gourtsoyiannis, N.6
-
46
-
-
68149084824
-
Expression of OATP1B3 determines uptake of Gd-EOBDTPA in hepatocellular carcinoma
-
19404564
-
Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, Taura K, Yasuchika K, Nitta T, Ikai I, Uemoto S. Expression of OATP1B3 determines uptake of Gd-EOBDTPA in hepatocellular carcinoma. J Gastroenterol 2009, 44:793-798. 10.1007/s00535-009-0056-4, 19404564.
-
(2009)
J Gastroenterol
, vol.44
, pp. 793-798
-
-
Narita, M.1
Hatano, E.2
Arizono, S.3
Miyagawa-Hayashino, A.4
Isoda, H.5
Kitamura, K.6
Taura, K.7
Yasuchika, K.8
Nitta, T.9
Ikai, I.10
Uemoto, S.11
-
47
-
-
77956112733
-
Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging-correlation with molecular transporters and histopathologic features
-
20663969
-
Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W, Kozaka K, Yoneda N, Yamashita T, Kaneko S, Nakanuma Y. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR imaging-correlation with molecular transporters and histopathologic features. Radiology 2010, 256:817-826. 10.1148/radiol.10092214, 20663969.
-
(2010)
Radiology
, vol.256
, pp. 817-826
-
-
Kitao, A.1
Zen, Y.2
Matsui, O.3
Gabata, T.4
Kobayashi, S.5
Koda, W.6
Kozaka, K.7
Yoneda, N.8
Yamashita, T.9
Kaneko, S.10
Nakanuma, Y.11
-
48
-
-
67049172143
-
Gadoxetic-acid enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma
-
19457834
-
Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK. Gadoxetic-acid enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 2009, 192:1675-1681. 10.2214/AJR.08.1262, 19457834.
-
(2009)
AJR Am J Roentgenol
, vol.192
, pp. 1675-1681
-
-
Kim, S.H.1
Kim, S.H.2
Lee, J.3
Kim, M.J.4
Jeon, Y.H.5
Park, Y.6
Choi, D.7
Lee, W.J.8
Lim, H.K.9
-
49
-
-
33846212284
-
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
-
17178882
-
Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res 2006, 66:11851-11858. 10.1158/0008-5472.CAN-06-1377, 17178882.
-
(2006)
Cancer Res
, vol.66
, pp. 11851-11858
-
-
Liu, L.1
Cao, Y.2
Chen, C.3
Zhang, X.4
McNabola, A.5
Wilkie, D.6
Wilhelm, S.7
Lynch, M.8
Carter, C.9
-
50
-
-
84866606067
-
Complications of microwave ablation for liver tumors: results of a multicenter study
-
21833809, for the Collaborative Italian Group using AMICA system
-
Livraghi T, Meloni F, Solbiati L, Zanus G, . for the Collaborative Italian Group using AMICA system Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol 2012, 35:868-874. 10.1007/s00270-011-0241-8, 21833809, for the Collaborative Italian Group using AMICA system.
-
(2012)
Cardiovasc Intervent Radiol
, vol.35
, pp. 868-874
-
-
Livraghi, T.1
Meloni, F.2
Solbiati, L.3
Zanus, G.4
-
51
-
-
0036730805
-
Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy
-
Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002, 68:827-831.
-
(2002)
Am Surg
, vol.68
, pp. 827-831
-
-
Bloomston, M.1
Binitie, O.2
Fraiji, E.3
Murr, M.4
Zervos, E.5
Goldin, S.6
Kudryk, B.7
Zwiebel, B.8
Black, T.9
Fargher, S.10
Rosemurgy, A.S.11
-
52
-
-
46249116195
-
Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study
-
18486261
-
Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, Della Pina C, Bargellini I, Cioni D, Oliveri F, De Simone P, Bartolozzi C, Brunetto M, Filipponi F. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J Hepatol 2008, 49:217-222. 10.1016/j.jhep.2008.03.021, 18486261.
-
(2008)
J Hepatol
, vol.49
, pp. 217-222
-
-
Lencioni, R.1
Crocetti, L.2
Petruzzi, P.3
Vignali, C.4
Bozzi, E.5
Della Pina, C.6
Bargellini, I.7
Cioni, D.8
Oliveri, F.9
De Simone, P.10
Bartolozzi, C.11
Brunetto, M.12
Filipponi, F.13
-
53
-
-
84874771937
-
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial
-
23269991
-
Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013, 31:426-432. 10.1200/JCO.2012.42.9936, 23269991.
-
(2013)
J Clin Oncol
, vol.31
, pp. 426-432
-
-
Peng, Z.W.1
Zhang, Y.J.2
Chen, M.S.3
Xu, L.4
Liang, H.H.5
Lin, X.J.6
Guo, R.P.7
Zhang, Y.Q.8
Lau, W.Y.9
-
54
-
-
84897067851
-
Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology
-
[Epub ahead of print 2013 May 30], 23719667
-
Bargellini I, Florio F, Golfieri R, Grosso M, Lauretti DL, Cioni R. Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology. Cardiovasc Intervent Radiol 2014, 37:438-444. [Epub ahead of print 2013 May 30], 10.1007/s00270-013-0656-5, 23719667.
-
(2014)
Cardiovasc Intervent Radiol
, vol.37
, pp. 438-444
-
-
Bargellini, I.1
Florio, F.2
Golfieri, R.3
Grosso, M.4
Lauretti, D.L.5
Cioni, R.6
-
55
-
-
84864052036
-
Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy
-
22142656
-
Lencioni R. Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy. Crit Rev Oncol Hematol 2012, 83:216-224. 10.1016/j.critrevonc.2011.10.008, 22142656.
-
(2012)
Crit Rev Oncol Hematol
, vol.83
, pp. 216-224
-
-
Lencioni, R.1
-
56
-
-
84860261590
-
Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): phase II, randomized, double-blind SPACE trial. [abstract LBA154]
-
Lencioni R, Llovet JM, Han G, Tak W-Y, Yang J, Leberre M-A, Niu W, Nicholson K, Meinhardt G, Bruix J. Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): phase II, randomized, double-blind SPACE trial. [abstract LBA154]. J Clin Oncol 2012, 30(Suppl 4):40.
-
(2012)
J Clin Oncol
, vol.30
, pp. 40
-
-
Lencioni, R.1
Llovet, J.M.2
Han, G.3
Tak, W.-Y.4
Yang, J.5
Leberre, M.-A.6
Niu, W.7
Nicholson, K.8
Meinhardt, G.9
Bruix, J.10
-
57
-
-
63749100778
-
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases
-
Epub 2009 Mar 2, 19255321
-
Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1572-1578. Epub 2009 Mar 2, 10.1200/JCO.2008.19.6329, 19255321.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1572-1578
-
-
Rusthoven, K.E.1
Kavanagh, B.D.2
Cardenes, H.3
Stieber, V.W.4
Burri, S.H.5
Feigenberg, S.J.6
Chidel, M.A.7
Pugh, T.J.8
Franklin, W.9
Kane, M.10
Gaspar, L.E.11
Schefter, T.E.12
-
58
-
-
0035154735
-
Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial
-
Herfarth KK, Debus J, Lohr F, Bahner ML, Rhein B, Fritz P, Höss A, Schlegel W, Wannenmacher MF. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001, 19:164-170.
-
(2001)
J Clin Oncol
, vol.19
, pp. 164-170
-
-
Herfarth, K.K.1
Debus, J.2
Lohr, F.3
Bahner, M.L.4
Rhein, B.5
Fritz, P.6
Höss, A.7
Schlegel, W.8
Wannenmacher, M.F.9
-
59
-
-
34247095550
-
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium
-
17448867
-
Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007, 68:13-23. 10.1016/j.ijrobp.2006.11.060, 17448867.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.68
, pp. 13-23
-
-
Kennedy, A.1
Nag, S.2
Salem, R.3
Murthy, R.4
McEwan, A.J.5
Nutting, C.6
Benson, A.7
Espat, J.8
Bilbao, J.I.9
Sharma, R.A.10
Thomas, J.P.11
Coldwell, D.12
-
61
-
-
84927703419
-
-
Accessed November 17, 2013, Bayesian networks
-
Bayesian networks http://www.pr-owl.org/basics/bn.php#pearl1988 Accessed November 17, 2013, Bayesian networks.
-
-
-
|